Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-45,079
Closed -$37.3K 1721
2025
Q3
$37.3K Buy
45,079
+16,517
+58% +$12.7K 0.01% 1032
2025
Q2
$21.8K Buy
+28,562
New +$31K ﹤0.01% 1196
2023
Q1
Sell
-1,679
Closed -$14.9K 2930
2022
Q4
$14.9K Buy
+1,679
New +$56.8K ﹤0.01% 2308
2022
Q3
Sell
-79
Closed -$10K 2824
2022
Q2
$10K Buy
+79
New +$11.9K ﹤0.01% 2052
2022
Q1
Sell
-35
Closed -$10K 2282
2021
Q4
$10K Buy
35
+2
+6% +$763 ﹤0.01% 1476
2021
Q3
$17K Buy
+33
New +$20.6K ﹤0.01% 1468
2019
Q3
Sell
-45
Closed -$16K 2229
2019
Q2
$16K Buy
45
+11
+32% +$4.44K ﹤0.01% 1967
2019
Q1
$15K Buy
+34
New +$14.8K ﹤0.01% 1695
2018
Q4
Sell
-38
Closed -$16K 2449
2018
Q3
$16K Buy
+38
New +$15.4K ﹤0.01% 2467
2018
Q2
Sell
-10
Closed -$11K 2794
2018
Q1
$11K Buy
10
+2
+25% +$2.1K ﹤0.01% 2604
2017
Q4
$7K Sell
8
-13
-62% -$16.7K ﹤0.01% 1685
2017
Q3
$34K Buy
21
+18
+600% +$29K ﹤0.01% 778
2017
Q2
$7K Sell
3
-3
-50% -$5.88K ﹤0.01% 818
2017
Q1
$12K Buy
+6
New +$12.5K ﹤0.01% 858
2015
Q4
Sell
-5
Closed -$15K 320
2015
Q3
$15K Buy
+5
New +$18.5K 0.02% 188

Other funds holding IBIO

Two Sigma Securities's IBIO Position: Q4 2025 in Review

Two Sigma Securities sold out of iBio (IBIO) in Q4 2025, closing a stake of 45,079 shares — an estimated $37.3K sold.

Two Sigma Securities first reported a position in IBIO in Q3 2015 and held it in 15 quarters. The position peaked at $37.3K in Q3 2025. 50 funds tracked by Wall St. Rank hold IBIO as of Q4 2025.

  • Two Sigma Securities reported no remaining iBio position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 45,079 iBio shares in Q4 2025, an estimated $37.3K.
  • Two Sigma Securities first reported a position in iBio in Q3 2015 and held it in 15 quarters.
  • Two Sigma Securities's iBio position peaked at $37.3K in Q3 2025.
  • 50 funds tracked by Wall St. Rank held iBio as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.